Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan.
Arabinomannan (AM) is a polysaccharide antigen of the mycobacterial capsule. However, it is uncertain whether AM constitutes an immunologically distinct fraction of Mycobacterium tuberculosis. In this study, we analyzed the repertoire and specificity of antibodies to AM by using AM-binding murine monoclonal antibodies (MAbs) and human serum samples. Murine MAbs were found to be diverse in their specificity to AM and cross-reactivity with other arabinose-containing mycobacterial polysaccharides, with MAb 9d8 binding exclusively to AM. Human antibodies to AM were detected in serum samples from patients with pulmonary tuberculosis (TB), as well as in those from healthy, purified protein derivative-negative controls, with significantly higher titers among patients. The binding of human antibodies to AM was inhibited by MAb 9d8 in three patients with TB but not in controls. MAb 5c11, which recognizes other mycobacterial arabinose-containing carbohydrates in addition to AM, inhibited the binding of serum samples from 75% of patients and 76% of controls. Analysis of human antibodies with murine MAbs to human V(H) determinants demonstrated diversity among antibodies to AM with qualitative and quantitative differences compared with antibodies to lipoarabinomannan. In summary, our study suggests that antibodies to AM are diverse and heterogeneous with respect to antigen recognition and V(H) determinant expression, with human serum samples containing different subsets of antibodies to AM with the specificities of AM-binding murine MAbs. One MAb and a subset of human antibodies bind AM specifically, suggesting that this polysaccharide is antigenically distinct and is expressed in human infection.
Navoa
Josephine Anne D
JA
Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, New York 10461, USA.
Laal
Suman
S
Pirofski
Liise-Anne
LA
McLean
Gary R
GR
Dai
Zhongdong
Z
Robbins
John B
JB
Schneerson
Rachel
R
Casadevall
Arturo
A
Glatman-Freedman
Aharona
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000235:genetics / Q000276:immunology*; D000916:Antibody Diversity; D000918:Antibody Specificity; D016022:Case-Control Studies; D016384:Consensus Sequence; D003429:Cross Reactions; D005260:Female; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics; D008297:Male; D008351:Mannans / Q000097:blood / Q000276:immunology*; D008875:Middle Aged; D008969:Molecular Sequence Data; D009169:Mycobacterium tuberculosis / Q000737:chemistry*; D011135:Polysaccharides, Bacterial / Q000097:blood / Q000276:immunology*; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000382:microbiology
D000907:Antibodies, Bacterial; D007135:Immunoglobulin Variable Region; D008351:Mannans; D011135:Polysaccharides, Bacterial; C012189:arabinomannan